On August 20, 2026, a trial status update was recorded for a study involving angiotensin ii. The study, titled "Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany," is registered under identifier NCT06675552. Its current status is listed as active, not recruiting. No phase designation was provided for this study, consistent with its non-interventional design. The study focuses on guideline directed medical therapy for patients with heart failure in Germany. This status update indicates that participant enrollment has concluded or paused, while the study itself continues. No outcomes, results, or efficacy data have been reported as part of this update. The listing does not specify a completion date or additional details beyond the current status. Readers should note that this is strictly a status update and does not reflect any findings from the study. Further information may become available as the trial progresses. For additional context on angiotensin ii, readers can consult the compound overview.
Angiotensin II Study NCT06675552 Now Active, Not Recruiting
See the full angiotensin ii overview
Source: https://clinicaltrials.gov/study/NCT06675552